Santarus Uceris Launch To Include Heavy Copay Assistance For First Six Months
This article was originally published in The Pink Sheet Daily
Executive Summary
The San Diego biotech plans to add 85 reps to its sales force in preparation for a launch in March following approval of its ulcerative colitis drug.